HolidayBlogging

Tag: lungs

  • Pulmonary Fibrosis: Diagnosis and Treatment – Health Cages

    Pulmonary Fibrosis: Diagnosis and Treatment – Health Cages

    Pulmonary fibrosis refers to a lung disease which results in scarring of the lungs. It becomes difficult to breathe as well as get sufficient oxygen. Scarring continues to get worse over time and can disrupt an individual’s daily routine.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    There is no cure for the disease, but it can significantly improve in well diagnosed and treated patients.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    This article focuses on the diagnostic methods of pulmonary fibrosis, treatment options, and disease management in daily life.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    A Closer Look at the Disease

    Pulmonary fibrosis occurs as a result of damage and scarring of the lungs. The scar formation results in stiff lung tissues which makes it very difficult for oxygen to pass into the blood. It becomes highly difficult to breathe deeply or perform physical activities.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    In some instances, doctors remain unsure of the underlying causes. In this scenario, it is referred to as Idiopathic Pulmonary Fibrosis (IPF). A few other causes may involve:

    • Exposure to dust, smoke, or chemicals
    • Autoimmune disease: lupus or rheumatoid arthritis
    • Radiation therapy (most common for cancer care)
    • Specific medicines like chemotherapy, heart medicine, or medicinal drugs

    Risk Factors

    Some individuals have higher chances of getting pulmonary fibrosis. These are known as risk factors, and include:

    (adsbygoogle=window.adsbygoogle||[]).push({})

    Age: Mostly prevalent in patients older than 50 years of age

    Gender: Slightly more prevalent in males

    Smoking: Greater lung damage with time

    Occupational exposure: Mining, farming, and construction

    Family: Positive family history of lung disease

    Medical: Autoimmune diseases like Scleroderma or Sarcoidosis

    All these risks aid both the patient and the doctor in making an early diagnosis in case the disease progresses.

    Diagnosis Methods

    Diagnosis of pulmonary fibrosis tends to be more time-consuming and arrives at a clear conclusion to identifying the disease step-by-step. Some steps include:

    Medical History

    A doctor inquires about an illness previous to that and one’s occupation including smoking and exposure to dust or chemicals. Family diseases are also considered.

    Auscultation (of the lungs)

    Doctors listen to the lungs using a stethoscope. If scarring took place, crackling noise may be present.

    Imaging Tests Chest X-ray

    Describes if damage or scarring has occurred in the lungs.

    High-Resolution CT Scan: Provides clearer, more intricate pictures of the lungs.

    Breathing Tests

    These tests evaluate pulmonary function. They determine the amount of air exhaled and the amount of oxygen consumed.

    Spirometry Lung volume test Diffusing capacity test

    Oxygen Tests Pulse oximeter (placed on your finger) helps check if oxygen levels are suboptimal. Blood samples might also be taken. Blood Tests Helps in excluding other conditions such as infections and autoimmune conditions.

    Lung Biopsy

    At times, examiners require visual analysis of pulmonary tissues under a microscope. This procedure can be performed through a bronchoscope or surgically if deemed necessary.

    Treatment Options

    There is no cure for pulmonary fibrosis but treatment can help in managing it. Its main aim is to alleviate symptoms, limit complications, and improve breathing.

    Medications 

    Pirfenidone (Esbriet)  

    This drug may increase the quality of life of a patient with lung scarring while also potentially increasing life expectancy. Patient care programs can help lower the high Pirfenidone price, and insurance support often makes it more affordable.

    Corticosteroids (like Prednisone)

    Inflammation of the lungs is a common problem, and Prednisone helps alleviate this. It’s also very cost effective and available at a low Prednisone price.

    Nintedanib (Ofev)  

    Nintedanib treats lung scarring caused by a fibrosis disease by restricting some scar tissue generating proteins. Though the Nintedanib price is fairly expensive, it does have some saving plans.

    Azathioprine

    Immunosuppressant’s such as Azathioprine work sometimes with steroids. The general price of Azathioprine is low and often included in several health insurance plans.

    Oxygen Therapy

    Oxygen assists the body when the lungs cannot provide enough on their own. It can be applied:

    • During Exercise
    • Night time
    • Throughout the day for extreme conditions
    • This therapy improves energy and helps with breathlessness.

    Pulmonary Rehabilitation

    This is a unique course that shows patients how to stay active and exercise to achieve better oxygen flow. It often features:

    • Breathing Techniques
    • Mild Aerobic Exercises
    • Diet and health guidance
    • Mental health care counselling

    Lung Transplant

    A lung transplant is required in more severe instances. The operation involves replacing damaged lungs with healthy lungs obtained from a donor. Hospitals specializing in this surgery include the Cleveland Clinic and the Mayo Clinic. Transplants enhance breathing abilities, as well as life expectancy.

    Healthy Habits Matter

    It is crucial to take care of your health when you are living with pulmonary fibrosis. Here are some suggestions that would help:

    No smoking: Smoking is detrimental to the lungs.

    Stay active: Walking or performing light exercises can keep the lungs active.

    Healthy eating: Healthy diet helps fight infections. Consume vegetables, fruits, and lean proteins.

    Get good rest: Helps your body recover.

    Wash hands: These practices keep sick peers at bay

    Get Vaccinated: It is key to get vaccinated for flu and pneumonia for those living with any respiratory condition.

    Monitoring the Disease

    Doctors will continuously monitor your condition to ascertain if it is worsening or improving. Follow up visits may include, but not limited to:

    • Tests to ascertain lung functionality. Oxygen levels assessment. Chest scans. Blood tests.
    • Keeping up with these appointments allows you to fine-tune your treatment plan if need be.

    Hope of Better Treatment

    Scientists are working endlessly on methods to treat or even reverse scarring for pulmonary fibrosis. Several hospitals and research centers have come up with clinical trials which allow patients access to experimental treatments prior to widespread availability.

    Genentech and Boehringer Ingelheim are some of the companies working to develop better alternatives. Future care also includes promising prospects with stem cell therapy and gene research.

    Conclusion

    Pulmonary fibrosis is a life threatening disease that alters the mechanics of breathing. The damage done to the lungs makes oxygen supply difficult which can lead to fatigue and shortness of breath. Even so, early diagnosis with medication, oxygen, and rehab allows people to live a meaningful life. Regular check-ups along with new treatments and healthy living improve the lives of patients suffering from this condition.

  • 4 Non-invasive Sarcoidosis Treatment Options – Health Cages

    4 Non-invasive Sarcoidosis Treatment Options – Health Cages

    Sarcoidosis is a chronic inflammatory disease that affects people across the globe, often attacking the lungs, skin, and lymph nodes. Traditionally, the treatment protocol involves corticosteroids and other immunosuppressants, but these come with a range of side effects that patients find difficult to tolerate over the long term. Thankfully, new scientific research and innovative therapies are opening doors for safer, non-invasive alternatives.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    In recognition of Sarcoidosis Awareness Month—celebrated each April—we dive into four promising noninvasive sarcoidosis treatment options that reshape how patients manage their symptoms and reclaim their quality of life.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    1. Efzofitimod: The Protein with a Promise

    One of the most talked-about breakthroughs in recent months is efzofitimod, an investigational immunomodulator developed by aTyr Pharma, a San Diego-based biotech firm. This engineered version of a naturally occurring protein aims to reduce inflammatory cell activity that contributes to sarcoidosis.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    In March 2025, researchers at Scripps Research in California, in collaboration with aTyr, published a compelling study in Science Translational Medicine. Their findings revealed that efzofitimod significantly improved lung function and reduced inflammation markers in patients with pulmonary sarcoidosis.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    “Efzofitimod represents a novel approach that targets the root of inflammation rather than just treating the symptoms,” said Dr. Sanjay Shukla, CEO of aTyr Pharma. “Our early data shows real promise for safer, long-term disease management.”

    The Phase 3 EFZO-FIT™ clinical trial, currently underway, is enrolling patients from multiple locations across the United States, including Boston, Atlanta, and Chicago. If successful, it may become the first FDA-approved biologic specifically for sarcoidosis.

    (adsbygoogle=window.adsbygoogle||[]).push({})

    2. Targeting ILC1 Cells: Unlocking New Diagnostics and Treatments

    Another promising development comes from the Perelman School of Medicine at the University of Pennsylvania. In September 2024, a team of immunologists discovered that sarcoidosis patients have abnormally high levels of type 1 innate lymphoid cells (ILC1S) in granulomas—those clumps of immune cells that are the hallmark of the disease.

    This discovery not only improves our understanding of how sarcoidosis develops but also provides a non-invasive biomarker for diagnosis. More importantly, targeting ILC1S may offer a treatment avenue that avoids the pitfalls of long-term steroid use.

    “Knowing exactly which immune cells are overactive gives us a bullseye,” said lead researcher Dr. Andrea Stocco. “We’re not just shooting in the dark anymore.”

    The American Thoracic Society hailed their findings as a potential game-changer, emphasising the importance of early detection and personalised care in chronic lung conditions.

    3. Immunomodulatory Therapies & Sensonica’s Non-invasive Approach

    While corticosteroids remain the first line of defence, patients and clinicians are increasingly looking for gentler therapies that still get the job done. Enter immunomodulatory agents like methotrexate, azathioprine, and hydroxychloroquine, commonly used off-label to suppress immune activity with fewer side effects.

    But more holistic and tech-driven approaches are beginning to catch on as well. One such resource is noninvasive sarcoidosis treatment by Sensonica, which promotes patient-friendly, low-risk solutions designed to complement or replace aggressive medications.

    Sensonica emphasises the role of wearable technology, guided breathing exercises, and digital monitoring platforms to track symptoms, inflammation levels, and even oxygen saturation, all from the comfort of home.

    “We’re seeing a shift from reactive to proactive care,” said Sensonica co-founder Rachel Lim. “Patients can now monitor flare-ups in real time and adjust lifestyle factors that contribute to inflammation. It’s empowering.”

    Such approaches align with current telehealth trends and are especially beneficial for rural patients or those with limited access to specialist care.

    4. Support Networks and Awareness: Healing Through Community

    Treatment isn’t always about pills and procedures. Emotional support, education, and community are also essential, especially when navigating a chronic illness. That’s why April’s Sarcoidosis Awareness Month, spearheaded by the Foundation for Sarcoidosis Research (FSR), is so vital.

    According to FSR, over 175,000 Americans are currently diagnosed with sarcoidosis, while the global number exceeds 1.2 million. It’s more prevalent among African Americans, particularly women aged 20 to 40.

    “I was misdiagnosed for years,” said sarcoidosis survivor Lisa Reynolds, who now leads a support group in Dallas, Texas. “Joining a community helped me understand that I’m not alone. I finally found my voice—and a better treatment plan.”

    Through webinars, patient toolkits, and partnerships with local hospitals, organisations like FSR are helping patients take charge of their care. In 2025, their “Stand Up for Sarc” campaign featured events in New York City, Los Angeles, and Seattle, spotlighting stories from real patients and encouraging more research funding.

    Bridging the Gap Between Hope and Healing

    With scientific advances and patient-centred innovation gaining traction, the landscape of sarcoidosis care is evolving for the better. Non-invasive treatments are no longer a pipe dream—they’re fast becoming a reality for thousands of patients.

    In this new era of healthcare, it’s clear that an ounce of prevention is worth a pound of cure. Whether it’s lab-grown proteins like efzofitimod, targeting specific immune cells, or harnessing digital tools to track your health, there’s more than one way to tackle sarcoidosis, without resorting to invasive procedures or life-altering side effects.

    If you’re living with sarcoidosis, talk to your physician about emerging treatments, clinical trials, or digital care programs that could work for your lifestyle and medical profile. As always, knowledge is power, and staying informed may be the best medicine of all.